Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
MERCK & CO., Inc. (NY: MRK)
57.47 USD  +0.21 (+0.37%)
Official Closing Price  /  Updated: 6:40 PM EST, Mar 7, 2014  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 10,634,294
Open 57.35
Bid (Size) 57.47 (2200)
Ask (Size) 57.48 (2200)
Prev. Close 57.26
Today's Range 57.10 - 57.57
52wk Range 42.87 - 57.65
Shares Outstanding 2,940,622,461
Dividend Yield 3.03%
Performance
YTD
+16.12%
+16.12%
1 Month
+7.40%
+7.40%
3 Month
+17.74%
+17.74%
6 Month
+20.96%
+20.96%
1 Year
+31.57%
+31.57%
Top News
More News
10 Big-Name Stocks Going Ex-Dividend Next Week (Mar 10-14)
March 06, 2014
Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its upcoming dividend payout. For more information, check... Read More
category leg , kss , gamestop , and 18 more.
from Dividend Daily
Smith & Wesson Holding Corp(NASDAQ:SWHC) Surging On Earnings Beat
March 05, 2014
NASDAQ:SWHC, NASDAQ:CSIQ, NASDAQ:DRYS, NASDAQ:ZNGA, NYSE:HOV Related posts: Facebook Inc (FB) Likely To Beat Earnings Did SolarCity Corp (SCTY) Earnings Crush The Solar ETF Rally? Market Enters Busy... Read More
category NYSE:EES , Smith & Wesson Holding Corp , NASDAQ:CSIQ , and 4 more.
from ETF DAILY NEWS
More News
Read More
Merck’s Investigational Hepatitis C Treatment Regimen MK-5172/MK-8742 Shows Robust Anti-HCV Activity in HIV/HCV Co-Infected Patients with HCV Genotype 1 Infection
March 05, 2014
from Business Wire News Releases
New 96-Week ACTG Study Results Presented at CROI 2014; First Large Study Comparing ISENTRESS® (raltegravir) Regimen to Two Protease Inhibitor Regimens in Previously Untreated Adults with HIV-1
March 05, 2014
from Business Wire News Releases
Merck’s Investigational HIV Therapy, Doravirine (MK-1439), Demonstrates Antiviral Activity in Phase 2B Study of Treatment-Naïve Adults
March 05, 2014
from Business Wire News Releases
Alnylam closes $175M purchase of Merck subsidiary
March 06, 2014
category Biotech , John Maraganore , Alnylam Pharmaceuticals , and 6 more.
from Business Journals
Goldman Sachs Maintains Conviction Buy on Abbvie (ABBV)
March 06, 2014
from StreetInsider.com News Articles
Merck: 52-Week High Recently Eclipsed (MRK)
March 06, 2014
from Comtex SmarTrend® News Briefs
15.3% Return Seen to Date on SmarTrend Merck Call (MRK)
March 06, 2014
from Comtex SmarTrend® News Briefs
UPDATE 1-Merck KGaA's profit up as cutbacks cancel out forex pain
March 06, 2014
category companyNews
from Reuters: Company News
Merck & - Daily Trading Report
March 06, 2014
from AVAFIN
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here